Guided Therapeutics Inc (GTHP) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Guided Therapeutics Inc   (GTHP)


Guided Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Guided Therapeutics Inc 's ROA in the second quarter of 2026?
Guided Therapeutics Inc recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -188.59%.

However, within the Healthcare sector 882 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4565, from total ROA ranking in the first quarter of 2026 at 5284.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 127.98 % 65.87 % 112.19 % -27.7 % -24.86 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -4 -4 -3 -3 -3
Return On Assets (TTM) -188.59 % -237.26 % -222.95 % -251.38 % -224.44 %
GTHP's Total Ranking # 4565 # 5284 # 4655 # 4703 # 4747
Total Assets (TTM) in million 2 2 3 1 1
Seq. Total Assets Change 33.6 % -45.14 % 223.81 % -3.94 % -2.79 %
Seq. Net Income Change - - - - -

GTHP's 5 Years Annual ROA >> Back to GTHP Management Effectiveness >> Compare GTHP ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 201
Sector # 883
Overall # 4505

Return On Assets Statistics
High Average Low
243.06 %
-279.07 %
-2016.2 %
(Dec 31 2018)   (Sep 30 2019)





Financial Statements
Guided Therapeutics Inc 's Assets $ 2 million GTHP's Balance sheet
Guided Therapeutics Inc 's Income $ -1 million Quarterly GTHP's Income Statement
GTHP's Income by Division See GTHP's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -3.92 % -17.44 % -50.42 % 65 % 51.11 %
Total Assets in million 1 1 2 3 2
Y / Y Net Income Change - - - - -
Net Income in million -3 -2 -4 -4 -2
Annual Return On Assets -241.39 % -175.4 % -214.98 % -128.97 % -119.17 %

GTHP's 5 Years Annual ROA >> Back to GTHP Management Effectiveness >> Compare GTHP ROA to its Competitors



More Return On Assets Ratios
GTHP's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GTHP's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GTHP's Competitors
Subscribers only: Roa for Guided Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for GTHP's Customers

You may also want to know
GTHP's Roi GTHP's Inventory Turnover Ratio GTHP's Growth Rates GTHP's Dividend Comparisons
GTHP's Profitability Ratios GTHP's Asset Turnover Ratio GTHP's Dividend Growth
GTHP's Roe GTHP's Valuation Ratios GTHP's Financial Strength Ratios GTHP's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-01T19:57:40+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.